- Home
- MLYS vs WB Comparison
MLYS vs WB Comparison
Compare MLYS & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- WB
- Stock Information
- Founded
- MLYS 2019
- WB 2009
- Country
- MLYS United States
- WB China
- Employees
- MLYS N/A
- WB N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- WB Computer Software: Programming Data Processing
- Sector
- MLYS Health Care
- WB Technology
- Exchange
- MLYS Nasdaq
- WB Nasdaq
- Market Cap
- MLYS 2.9B
- WB 2.8B
- IPO Year
- MLYS 2023
- WB 2014
- Fundamental
- Price
- MLYS $40.40
- WB $10.05
- Analyst Decision
- MLYS Strong Buy
- WB Buy
- Analyst Count
- MLYS 6
- WB 2
- Target Price
- MLYS $46.40
- WB $14.00
- AVG Volume (30 Days)
- MLYS 1.5M
- WB 1.1M
- Earning Date
- MLYS 11-10-2025
- WB 11-18-2025
- Dividend Yield
- MLYS N/A
- WB 16.30%
- EPS Growth
- MLYS N/A
- WB 9.65
- EPS
- MLYS N/A
- WB 1.41
- Revenue
- MLYS N/A
- WB $1,762,960,000.00
- Revenue This Year
- MLYS N/A
- WB $0.82
- Revenue Next Year
- MLYS N/A
- WB $2.15
- P/E Ratio
- MLYS N/A
- WB $7.11
- Revenue Growth
- MLYS N/A
- WB 1.37
- 52 Week Low
- MLYS $8.24
- WB $7.10
- 52 Week High
- MLYS $47.65
- WB $12.96
- Technical
- Relative Strength Index (RSI)
- MLYS 49.69
- WB 30.08
- Support Level
- MLYS $36.56
- WB $10.30
- Resistance Level
- MLYS $47.65
- WB $10.91
- Average True Range (ATR)
- MLYS 3.45
- WB 0.24
- MACD
- MLYS -0.00
- WB -0.05
- Stochastic Oscillator
- MLYS 50.18
- WB 0.68
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About WB Weibo Corporation
Weibo Corp is a China-based company mainly engaged in the social media advertising business for people to create, discover and distribute content. The company's activities include Advertising and Marketing, which mainly provides a full range of advertising customization and marketing solutions. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The Company's main product is the social platform Weibo.